# Decibel Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/decibel-bio

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.decibel.bio
- Total disclosed funding: $12M
- Latest round: Series A (Mar 5, 2025)
- Investors on record: 4

## About

Decibel Bio is an innovative biotechnology company that specializes in programming plant biology to enhance agricultural crop traits through advanced epigenetic techniques.Decibel Bio focuses on developing a unique platform for plant biology, allowing for tailored crop traits through methods like foliar sprays. Founded in 2024 in Berkeley, US, the company successfully raised USD 12.000 mn in venture funding from Bayer AG, Breakthrough Energy Ventures, Future Ventures, and Syngenta on March 5, 2025, marking its first significant investment. The founder's history includes experience in agricultural innovation, although specific previous ventures are not detailed.Decibel Bio specializes in an innovative platform that allows for the programming of plant biology, making it possible to provide crops with tailored traits through methods such as foliar sprays or seed treatments. This approach enables growers to enhance crop characteristics like yield, disease resistance, nutrient uptake, and stress tolerance, effectively adapting to the unique challenges posed by changing environmental conditions and market demands. The core product offerings revolve around their patented epigenome-driven foundational models, which can predict agronomic outcomes more accurately than traditional crop models. The primary customers for these services are seed breeders, agricultural companies, and growers seeking to improve crop performance. Decibel Bio’s products are positioned in various global markets, particularly in regions where modern agriculture faces significant challenges due to climate change and resource variability.Decibel Bio's revenue model is structured around partnerships and collaborations with seed breeders and agricultural companies, facilitating the implementation of their epigenetic programming technology. Transactions typically occur through direct agreements where clients engage Decibel for the application of their innovative crop trait solutions, thereby enhancing the agricultural yield and resilience of their products. The company generates revenue through these collaborative arrangements, enabling seed breeders to access faster, more efficient trait development processes. Specific pricing plans and revenue structures are tailored to the nature of the contracts and the scope of services provided, which may vary based on client needs and project size. The flagship offerings are designed to meet the evolving demands of growers, ensuring a robust and adaptive supply chain within the agricultural sector.In March 2025, Decibel Bio raised USD 12.000 mn in venture funding to develop and expand its crop epigenetic platform. The company aims to launch new products designed to enhance crop resilience and yield in the near future, with specific timelines yet to be disclosed. Plans for expansion target emerging agricultural markets in Europe and Asia by 2026, where the need for innovative agricultural solutions is growing. The recent funding will support these developments, further strengthening their position in the agricultural biotechnology sector.

## Funding rounds

- Series A, Mar 5, 2025, $12M — Syngenta, Bayer AG, Breakthrough Energy Ventures, Future Ventures

## Investors

- Syngenta — Series A
- Bayer AG — Series A
- Breakthrough Energy Ventures (https://capitalatlas.ai/funds/breakthrough-energy-ventures) — Series A
- Future Ventures — Series A